Home›Companies›Biotech & Pharma›RLL

RLL, LLC

Develops an oral cancer drug for patients.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Apr 6, 2026·Suggest an edit

About RLL

RLL is a private company based in Lutherville, Maryland. It has reported $12,721,150 raised in seven offerings on Form D since October 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 6, 2026Apr 6, 2026$1,984,621target not set11$180KDebt, Options, Securities on exercise, The securities are simple agreements for future equity (SAFEs) that also accrues interest with a valuation capRule 506(b)Form D ↗
Not yetJun 24, 2025$0target not set0—Debt, Options, Securities on exercise, The securities are simple agreements for future equity (SAFEs) that also accrues interestRule 506(b)Form D ↗
Not yetDec 2, 2024$0target not set0—Options, Securities on exercise, The securities are simple agreements for future equity (SAFEs)Rule 506(b)Form D ↗
Jul 26, 2021Jul 27, 2021$8,015,002target not set17$471KEquityRule 506(b)Form D ↗
Feb 25, 2020Feb 26, 2020$1,537,316of $2.6M target2$768KEquityRule 506(b)Form D ↗
Mar 27, 2019Apr 5, 2019$500,000of $1.0M target1$500KDebt, OptionsRule 506(b)Form D ↗
Sep 28, 2018Oct 9, 2018$684,211target not set1$684KEquityRule 506(b)Form D ↗
Total, seven offerings$12,721,150

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RLL's Form D filed Apr 6, 2026.

RH
LS
Lauren Schnaper
President and director
LM
Linda Malkas
Director
JT
Jonathan Thomas
Executive officer

Sources

  1. SECRLL, LLC filing history